Method of diagnosis of amyloidoses


Ontology type: sgo:Patent     


Patent Info

DATE

1993-12-14T00:00

AUTHORS

William E. Van Nostrand , Dennis D. Cunningham , Steven L. Wagner

ABSTRACT

A method of diagnosing a disease with cerebrovascular deposition of amyloid, including Alzheimer's disease, hereditary cerebral hemorrhage with amyloidosis-Dutch type and other amyloidoses, in a mammal is disclosed in which a sample of cerebrospinal fluid is obtained, the level of immunoreactivity toward a monoclonal antibody raised against native PN-2/βAPP or other amyloid precursor protein in the sample is measured, and this measured level is compared to the level of immunoreactivity toward this antibody in a sample fromNOTICE OF GOVERNMENT SUPPORTThis invention was made with Government support under Grant No. GM-31609 awarded by the National Institutes of Health. The Government has certain rights in this invention. American Cancer Society Grants CD 390 and BC 602/BE 22A provided further support for the development of this invention. More... »

Related SciGraph Publications

  • 1988-02. Enter a protease inhibitor in NATURE
  • JSON-LD is the canonical representation for SciGraph data.

    TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

    [
      {
        "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
        "about": [
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/3120", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "type": "DefinedTerm"
          }
        ], 
        "author": [
          {
            "name": "William E. Van Nostrand", 
            "type": "Person"
          }, 
          {
            "name": "Dennis D. Cunningham", 
            "type": "Person"
          }, 
          {
            "name": "Steven L. Wagner", 
            "type": "Person"
          }
        ], 
        "citation": [
          {
            "id": "sg:pub.10.1038/331478a0", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1007478991", 
              "https://doi.org/10.1038/331478a0"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1016/0092-8674(89)90177-3", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1020497171"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1016/0006-291x(89)92154-2", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1042590861"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1056/nejm198412133112406", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1048890350"
            ], 
            "type": "CreativeWork"
          }
        ], 
        "datePublished": "1993-12-14T00:00", 
        "description": "

    A method of diagnosing a disease with cerebrovascular deposition of amyloid, including Alzheimer's disease, hereditary cerebral hemorrhage with amyloidosis-Dutch type and other amyloidoses, in a mammal is disclosed in which a sample of cerebrospinal fluid is obtained, the level of immunoreactivity toward a monoclonal antibody raised against native PN-2/βAPP or other amyloid precursor protein in the sample is measured, and this measured level is compared to the level of immunoreactivity toward this antibody in a sample from

    NOTICE OF GOVERNMENT SUPPORT

    This invention was made with Government support under Grant No. GM-31609 awarded by the National Institutes of Health. The Government has certain rights in this invention. American Cancer Society Grants CD 390 and BC 602/BE 22A provided further support for the development of this invention.

    ", "id": "sg:patent.US-5270165-A", "keywords": [ "method", "diagnosis", "amyloidosis", "disease", "cerebrovascular", "amyloid", "Alzheimer's", "Cerebral Hemorrhage", "sample", "cerebrospinal fluid", "immunoreactivity", "monoclonal antibody", "PNS", "amyloid precursor protein", "measured level", "antibody", "government", "invention", "National Institute of Health", "right", "American Cancer Society", "BC", "development" ], "name": "Method of diagnosis of amyloidoses", "recipient": [ { "id": "https://www.grid.ac/institutes/grid.30389.31", "type": "Organization" } ], "sameAs": [ "https://app.dimensions.ai/details/patent/US-5270165-A" ], "sdDataset": "patents", "sdDatePublished": "2019-04-18T10:26", "sdLicense": "https://scigraph.springernature.com/explorer/license/", "sdPublisher": { "name": "Springer Nature - SN SciGraph project", "type": "Organization" }, "sdSource": "s3://com-uberresearch-data-patents-target-20190320-rc/data/sn-export/402f166718b70575fb5d4ffe01f064d1/0000100128-0000352499/json_export_02996.jsonl", "type": "Patent" } ]
     

    Download the RDF metadata as:  json-ld nt turtle xml License info

    HOW TO GET THIS DATA PROGRAMMATICALLY:

    JSON-LD is a popular format for linked data which is fully compatible with JSON.

    curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/patent.US-5270165-A'

    N-Triples is a line-based linked data format ideal for batch operations.

    curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/patent.US-5270165-A'

    Turtle is a human-readable linked data format.

    curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/patent.US-5270165-A'

    RDF/XML is a standard XML format for linked data.

    curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/patent.US-5270165-A'


     

    This table displays all metadata directly associated to this object as RDF triples.

    66 TRIPLES      15 PREDICATES      41 URIs      31 LITERALS      2 BLANK NODES

    Subject Predicate Object
    1 sg:patent.US-5270165-A schema:about anzsrc-for:3120
    2 schema:author N0ea5184424f94a95a45f1f7961f060c5
    3 schema:citation sg:pub.10.1038/331478a0
    4 https://doi.org/10.1016/0006-291x(89)92154-2
    5 https://doi.org/10.1016/0092-8674(89)90177-3
    6 https://doi.org/10.1056/nejm198412133112406
    7 schema:datePublished 1993-12-14T00:00
    8 schema:description <p>A method of diagnosing a disease with cerebrovascular deposition of amyloid, including Alzheimer's disease, hereditary cerebral hemorrhage with amyloidosis-Dutch type and other amyloidoses, in a mammal is disclosed in which a sample of cerebrospinal fluid is obtained, the level of immunoreactivity toward a monoclonal antibody raised against native PN-2/&#946;APP or other amyloid precursor protein in the sample is measured, and this measured level is compared to the level of immunoreactivity toward this antibody in a sample from</p><heading>NOTICE OF GOVERNMENT SUPPORT</heading><p>This invention was made with Government support under Grant No. GM-31609 awarded by the National Institutes of Health. The Government has certain rights in this invention. American Cancer Society Grants CD 390 and BC 602/BE 22A provided further support for the development of this invention.</p>
    9 schema:keywords Alzheimer's
    10 American Cancer Society
    11 BC
    12 Cerebral Hemorrhage
    13 National Institute of Health
    14 PNS
    15 amyloid
    16 amyloid precursor protein
    17 amyloidosis
    18 antibody
    19 cerebrospinal fluid
    20 cerebrovascular
    21 development
    22 diagnosis
    23 disease
    24 government
    25 immunoreactivity
    26 invention
    27 measured level
    28 method
    29 monoclonal antibody
    30 right
    31 sample
    32 schema:name Method of diagnosis of amyloidoses
    33 schema:recipient https://www.grid.ac/institutes/grid.30389.31
    34 schema:sameAs https://app.dimensions.ai/details/patent/US-5270165-A
    35 schema:sdDatePublished 2019-04-18T10:26
    36 schema:sdLicense https://scigraph.springernature.com/explorer/license/
    37 schema:sdPublisher N0bb8ccf17deb485eb3450af2ae0e8f17
    38 sgo:license sg:explorer/license/
    39 sgo:sdDataset patents
    40 rdf:type sgo:Patent
    41 N007e6c2504b34e948ba412800ab320da schema:name William E. Van Nostrand
    42 rdf:type schema:Person
    43 N0bb8ccf17deb485eb3450af2ae0e8f17 schema:name Springer Nature - SN SciGraph project
    44 rdf:type schema:Organization
    45 N0ea5184424f94a95a45f1f7961f060c5 rdf:first N007e6c2504b34e948ba412800ab320da
    46 rdf:rest N4e16ea2bf23b4d5bb1956cd71641f95c
    47 N31a916118b0d4a078cd5369bf6f5fd3d schema:name Steven L. Wagner
    48 rdf:type schema:Person
    49 N4187c8bbf463464aa850e05b695604bd schema:name Dennis D. Cunningham
    50 rdf:type schema:Person
    51 N4e16ea2bf23b4d5bb1956cd71641f95c rdf:first N4187c8bbf463464aa850e05b695604bd
    52 rdf:rest Na4db1e50fda649af9db7000db00e159f
    53 Na4db1e50fda649af9db7000db00e159f rdf:first N31a916118b0d4a078cd5369bf6f5fd3d
    54 rdf:rest rdf:nil
    55 anzsrc-for:3120 schema:inDefinedTermSet anzsrc-for:
    56 rdf:type schema:DefinedTerm
    57 sg:pub.10.1038/331478a0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1007478991
    58 https://doi.org/10.1038/331478a0
    59 rdf:type schema:CreativeWork
    60 https://doi.org/10.1016/0006-291x(89)92154-2 schema:sameAs https://app.dimensions.ai/details/publication/pub.1042590861
    61 rdf:type schema:CreativeWork
    62 https://doi.org/10.1016/0092-8674(89)90177-3 schema:sameAs https://app.dimensions.ai/details/publication/pub.1020497171
    63 rdf:type schema:CreativeWork
    64 https://doi.org/10.1056/nejm198412133112406 schema:sameAs https://app.dimensions.ai/details/publication/pub.1048890350
    65 rdf:type schema:CreativeWork
    66 https://www.grid.ac/institutes/grid.30389.31 schema:Organization
     




    Preview window. Press ESC to close (or click here)


    ...